WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Squire Servance
Senior Of Counsel
Patents and Innovations
sservance@wsgr.com

D212-453-2891

Download vCard
Open PDF
  • Strategic Life Sciences Advisor

    Squire’s cell biology and neuroscience and biomedical engineering background, combined with his experiences as a life sciences executive, investor, and attorney, grant him in-depth industry acumen and insights into what is needed to take innovative life science technologies from concept to commercialization.

  • Pragmatic Business and Legal Experience

    Squire’s experience as General Counsel and Corporate Secretary at Repligen Corporation and Associate General Counsel at Baxter International, Inc., where he was the chief legal advisor and a senior leadership member for the approximately $2 billion global pharmaceuticals business division, gives him a solid combination of practical business experience and an intimate understanding of the legal risks involved in running life sciences companies.

Squire Servance is Senior Of Counsel in the New York office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovation practice. Squire is an attorney and senior executive with extensive experience advising and leading life sciences organizations, including as managing partner of a biotech venture studio and fund and general counsel and corporate secretary for a Nasdaq listed life sciences company.

He has extensive expertise in strategic planning, patent counseling, legal strategy, M&A and licensing, risk management, and product commercialization, with deep knowledge about the unique challenges in the life sciences industry. Squire has also forged relationships with key life sciences industry stakeholders necessary to advance innovative products through the drug development process.

Experience

Squire Servance is Senior Of Counsel in the New York office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovation practice. Squire is an attorney and senior executive with extensive experience advising and leading life sciences organizations, including as managing partner of a biotech venture studio and fund and general counsel and corporate secretary for a Nasdaq listed life sciences company.

He has extensive expertise in strategic planning, patent counseling, legal strategy, M&A and licensing, risk management, and product commercialization, with deep knowledge about the unique challenges in the life sciences industry. Squire has also forged relationships with key life sciences industry stakeholders necessary to advance innovative products through the drug development process.

Education
  • J.D., Duke University School of Law, 2008
  • M.B.A., Duke University Fuqua School of Business, 2008
  • Certificate in Health Sector Management, Duke University Fuqua School of Business, 2008
  • B.S., Biomedical Engineering and Cell Biology & Neuroscience, Rutgers University, School of Engineering, 2004

    With Honors

Associations and Memberships
  • Trustee, Rutgers University
  • Trustee, The Wistar Institute
Admissions
  • Bar of the District of Columbia
  • State Bar of New Jersey
  • State Bar of New York
  • State Bar of Pennsylvania
  • U.S. District Court for the District of New Jersey
  • U.S. District Court for the Eastern District of Pennsylvania
  • U.S. Court of Appeals for the Tenth Circuit
  • U.S. Patent and Trademark Office
Credentials
Education
  • J.D., Duke University School of Law, 2008
  • M.B.A., Duke University Fuqua School of Business, 2008
  • Certificate in Health Sector Management, Duke University Fuqua School of Business, 2008
  • B.S., Biomedical Engineering and Cell Biology & Neuroscience, Rutgers University, School of Engineering, 2004

    With Honors

Associations and Memberships
  • Trustee, Rutgers University
  • Trustee, The Wistar Institute
Admissions
  • Bar of the District of Columbia
  • State Bar of New Jersey
  • State Bar of New York
  • State Bar of Pennsylvania
  • U.S. District Court for the District of New Jersey
  • U.S. District Court for the Eastern District of Pennsylvania
  • U.S. Court of Appeals for the Tenth Circuit
  • U.S. Patent and Trademark Office

Select Speaking Engagements

  • Pitch Competition Judge, BioNJ’s BioPartnering Conference, May 2024
  • Panelist, “Implications of Proposed FTC/DOJ Antitrust Rules on Life Sciences M&A and Innovation,” Congressional Staff Briefing, April 2024
  • Panelist, “What Every New General Counsel of a Start-Up Should Know,” National Bar Association’s Gateway to Success Conference, March 2024
  • Panelist, “Life Sciences Investing in Q4 & Outlook for 2024,” IndieBio NY’s Investor Salon, October 2023
  • Panelist, “Cultivating & Targeting Capital to DE&I,” Life Sciences PA’s Life Sciences Futures Conference, September 2023
  • Panelist, “Health Equity x Life Sciences,” Life Sciences Summit sponsored by the Garden State Bar Association and the Hispanic Bar Association of New Jersey, April 2023
Insights

Select Speaking Engagements

  • Pitch Competition Judge, BioNJ’s BioPartnering Conference, May 2024
  • Panelist, “Implications of Proposed FTC/DOJ Antitrust Rules on Life Sciences M&A and Innovation,” Congressional Staff Briefing, April 2024
  • Panelist, “What Every New General Counsel of a Start-Up Should Know,” National Bar Association’s Gateway to Success Conference, March 2024
  • Panelist, “Life Sciences Investing in Q4 & Outlook for 2024,” IndieBio NY’s Investor Salon, October 2023
  • Panelist, “Cultivating & Targeting Capital to DE&I,” Life Sciences PA’s Life Sciences Futures Conference, September 2023
  • Panelist, “Health Equity x Life Sciences,” Life Sciences Summit sponsored by the Garden State Bar Association and the Hispanic Bar Association of New Jersey, April 2023
Focus Areas
  • Biotech
  • Corporate Life Sciences
  • Emerging Companies and Venture Capital
  • Intellectual Property
  • Life Sciences
  • Medical Devices
  • Patents and Innovations
Recent Events
Speaking Engagements
NHS Clinical Entrepreneur Programme Big Pitch 2025
This annual Big Pitch event marks the commencement off the new cohort of the NHS Clinical Entrepreneur Programme and celebrates the remarkable achievements of our current Clinical Entrepreneurs. The event will feature main stage keynotes from senior DHSC and NHS leaders, partner panels, pitches from our entrepreneurs and an exhibition zone showcasing innovations from Clinical Entrepreneurs, innovators from other NHSE programmes and CEP partners. There will also be a range of expert satellite sessions and the opportunity to meet the CEP mentors.
Learn More
WSGR Events
The New Administration's First 90 Days – Impacts on Fundraising in the Life Sciences Industry
Our experienced panel will discuss the first 90 days of the new administration and its impact on fundraising and investment in the life sciences sector.
Learn More
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.